MedPath

Predictive factors for sarcopenia and malabsorption in high risk surgical oncological patients after cytoreductive surgery and HIPEC procedure

Completed
Conditions
muscle loss and HIPEC procedure
10017990
10014412
Registration Number
NL-OMON42927
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

Patients > 18 years that undergo CRS and HIPEC procedure at the University Medical Center Groningen (UMCG)

Exclusion Criteria

All patients not eligible for CRS and HIPEC procedure
not fit for surgery or
unable to provide written consent or inability to fill out questionnaires

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath